Three large Phase 3 efficacy studies conducted in Bangladesh, Malawi, and Nepal show that TCV is safe and protective against typhoid in children 9 months and older.
Three large Phase 3 efficacy studies conducted in Bangladesh, Malawi, and Nepal show that TCV is safe and protective against typhoid in children 9 months and older.